Seroprevalence of Trypanosoma cruzi infection among school-age children in the endemic area of Guatemala

American Journal of Tropical Medicine and Hygiene

Volumn 68, Issue 6, 2003, Pages 678-682

  Rizzo, Nidia R ^a   Arana, Byron A ^a   Diaz, Anaite ^a   Cordon Rosales, Celia ^a   Klein, Robert E ^b   Powell, Malcolm R ^b,c  

^a UNIVERSIDAD DEL VALLE DE GUATEMALA   (Guatemala)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHAGAS DISEASE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUATEMALA; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SCHOOL CHILD; SEROPREVALENCE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; VECTOR CONTROL; ADOLESCENT; ANIMAL; BLOOD; CHILD; EPIDEMIOLOGY; IMMUNOLOGY; PARASITOLOGY;

PROTOZOA; ROSA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

PROTOZOON ANTIBODY;

ADOLESCENT; ANIMALS; ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; CHILD; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUATEMALA; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES; TRYPANOSOMA CRUZI;

EID: 0043239113     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.68.678     Document Type: Article

References (11)

1. World Health Organization, 1991. Control of Chagas disease: report of a WHO expert committee. World Health Organ Tech Rep Ser 811: 1-95.
2. Schmunis GA, 1991. Trypanosoma cruzi, the etiologic agent of Chagas disease: status in the blood supply in endemic and nonendemic countries. Transfusion 31: 547-557.
3. Matta VR, 1992. Enfermedad de Chagas en Guatemala: Prevalencia y Transmisión Congénita. Cosenza H, Kroeger A, eds. Enfermedades Parasitarias de Mayor Prevalencia y Transmitidas pro Vectores en Centro America. Tegucigalpa, Honduras: Litografic Lopez, 59-70.
4. Schofield CJ, Dias JCP, 1999. The southern cone initiative against Chagas disease. Adv Parasitol 42: 1-27.
5. World Health Organization, 1994. Press release 1194. WHO/20-8, March 1994, Geneva: World Health Organization.
6. Greer GJ, Nix NA, Cordon-Rosales C, Hernandez B, MacVean CM, Powell MR. 1999. Seroprevalence of Trypanosoma cruzi in three rural communities in Guatemala. Pan Am J Public Health 6: 110-116.
7. McCormick TS, Rowland EC, 1989. Trypanosoma cruzi: cross-reactive anti-heart antibodies produced during infection in mice. Exp Parasitol 69: 393-401.
8. Leiby, DA, Wendel, S, Takaoka, DT, Fachini, RM, Oliveira, LC, Tibbals, MA, 2000. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent kits. J Clin Microbiol 38: 639-642.
9. Paz-Bailey G, Monroy C, Rodas A, Taburu R, Davies C, Lines J, 2002. Incidence of Trypanosoma cruzi infection in two Guatemalan communities. Trans R Soc Trop Med Hyg 96: 48-52.
10. de Andrade AL, Zicker F, Silva IG, Matelli CM, 1995. Risk factors for Trypanosoma cruzi infections among children in Central Brazil: a case control study in vector control settings. Am J Trop Med Hyg 52: 183-187.
11. Gurtler RE, Petersen RM, Cecere MC, Schweigmann NJ, Chuit R, Gualtieri JM, Wisnivesky-Colli C, 1994. Chagas disease in north-west Argentina: risk of domestic infestations by Triatoma infestans after a single community-wide application of deltamethrin. Trans R Soc Trop Med Hyg 88: 27-30.